Huge congratulations to our international Life Sciences & Healthcare team who swept the board last night with six prestigious awards at the LMG Life Sciences Awards EMEA 2023 held in London, making Bird & Bird the firm with the most wins at the event.
The team won the following organisational awards for their exceptional work:
- EMEA M&A Firm of the Year
- EMEA Patent Litigation Firm of the Year: Medical Devices
- EMEA Venture Capital Firm of the Year
- Netherlands Firm of the Year
We have also been recognised for our outstanding work in the following patent litigation case and acquisition:
- Impact Case of the Year: Fingolimod (led by Oliver Jan Juengst)
- Impact Deal of the Year: Dr Reddy’s Laboratories acquisition of Nimbus Health (led by Kai Kerger)
Marc Martens and Mark Hilton, co-heads of our International Life Sciences & Healthcare group, commented: “We are delighted to have won six categories at the LMG Life Sciences Europe Awards. These wins recognise not only the breadth of our expertise in the life sciences sector – from multijurisdictional patent litigation to high profile corporate transactions – but also the high calibre and complexity of work our clients trust us to deliver for them time and time again.”
To view the full list of awards and winners please click here.
The LMG Life Sciences Awards EMEA are prestigious awards that aim to recognise the most impactful, innovative and complex legal work carried out in the Life Sciences sector across a variety of different practice areas.
